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Abstract
Background  and  objectives:  Sympathectomy  is  one  of  the  therapies  used  in  the  treatment  of
chronic obstructive  arterial  disease  (COAD).  Although  not  considered  as  ﬁrst-line  strategy,  it
should be  considered  in  the  management  of  pain  difﬁcult  to  control.  This  clinical  case  describes
the evolution  of  a  patient  with  inoperable  COAD  who  responded  properly  to  the  lumbar  sympa-
thetic block.
Case  report:  A  female  patient,  afro-descendant,  69  years  old,  ASA  II,  admitted  to  the  algology
service due  to  refractory  ischemic  pain  in  the  lower  limbs.  The  patient  had  undergone  several
surgical procedures  and  conservative  treatments  without  success.  Vascular  surgery  considered
the case  as  out  of  therapeutic  possibility,  unless  limb  amputation.  At  that  time,  sympathectomy
was indicated.  After  admission  to  the  operating  room,  the  patient  was  monitored,  positioned
and sedated.  The  blockade  was  performed  with  the  aid  of  radioscopy,  bilaterally,  at  L2--L3--L4
right and  L3  left  levels.  On  the  right  side,  at  each  level  cited,  3  mL  of  absolute  alcohol  with
0.25% bupivacaine  were  injected  without  vasoconstrictor,  and  on  the  left  side  only  local  anes-
thetic. The  procedure  was  performed  uneventfully.  The  patient  was  discharged  with  complete
remission  of  the  pain.
Conclusion:  Neurolitic  block  of  the  lumbar  sympathetic  chain  is  an  effective  and  safe  treatment
option for  pain  control  in  patients  with  critical  limb  ischemia  patients  in  whom  the  only  possible
intervention  would  be  limb  amputation.
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Tratamento
Bloqueio  neurolítico  da  cadeia  simpática  lombar  melhora  dor  crônica  em  paciente
portadora  de  isquemia  crítica  de  membro  inferior
Resumo
Justiﬁcativa/objetivos:  A  simpatectomia  é  uma  das  terapêuticas  usadas  no  tratamento  da
doenc¸a arterial  obstrutiva  crônica  (DAOP).  Embora  não  seja  considerada  como  estratégia  de
primeira  linha,  deve  ser  lembrada  no  manejo  dos  quadros  de  dor  de  difícil  controle.  Este  caso
clínico descreve  a  evoluc¸ão  de  uma  paciente  portadora  de  DAOP  inoperável  que  respondeu
adequadamente  ao  bloqueio  simpático  lombar.
Relato  de  caso:  Paciente  do  sexo  feminino,  parda,  69  anos,  estado  físico  II,  acompanhada  no
servic¸o de  algologia  devido  a  dor  isquêmica  refratária  em  membros  inferiores.  A  paciente
já havia  sido  submetida  a  diversas  abordagens  cirúrgicas  e  tratamentos  conservadores,  sem
sucesso.  A  cirurgia  vascular  considerou  o  caso  como  fora  de  possibilidade  terapêutica,  a  não  ser
amputac¸ão do  membro.  Nesse  momento,  foi  indicada  simpatectomia.  Após  admissão  no  centro
cirúrgico, a  paciente  foi  monitorada,  posicionada  e  sedada.  O  bloqueio  foi  feito  com  auxílio
da radioscopia,  bilateralmente,  nos  níveis  L2-L3-L4  à  direita  e  L3  à  esquerda.  Do  lado  direito,
em cada  nível  citado,  foram  injetados  3  mL  de  álcool  absoluto  com  bupivacaína  0,25%  sem
vasoconstritor  e  do  lado  esquerdo  somente  o  anestésico  local.  O  procedimento  foi  feito  sem
intercorrências.  A  paciente  recebeu  alta  com  completa  remissão  da  dor.
Conclusão:  O  bloqueio  neurolítico  da  cadeia  simpática  lombar  é  uma  opc¸ão  de  tratamento
eﬁcaz e  segura  para  controle  da  dor  em  pacientes  portadores  de  isquemia  crítica,  nos  quais  a
única intervenc¸ão  possível  seria  a  amputac¸ão  do  membro.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.
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hronic  obstructive  arterial  disease  (COAD)  is  characterized
y  a  reduced  blood  ﬂow  in  the  lower  limbs  arterial  beds.  It
as  multiple  etiologies,  of  which  atherosclerosis  is  the  most
mportant.  Patients  with  this  disease  remain  asymptomatic
ntil  the  affected  vessel  lumen  has  an  obstruction  greater
han  50%,  when  an  intermittent  claudication  occurs.  In  the
ater  stages  of  the  disease,  pain  at  rest,  ulcers  and  gangrene,
nd  critical  signs  of  ischemia  occur.1
Data  from  American  studies  show  that  a  critical  ischemia
s  found  in  12%  of  the  adult  population  and  is  more  com-
on  in  the  elderly  and  in  males.2 The  treatment  is  based  on
he  revascularization  of  affected  arterial  territory,  either
sing  open  techniques,  such  as  bypass  surgery  or  through
ndovascular  and  stenting  procedures.3 In  some  cases,  the
utcome  is  poor  and  it  is  not  possible  to  re-establish  ade-
uate  blood  ﬂow.  Fortunately,  less  than  10%  of  patients  with
ritical  lower  limb  ischemia  (CLI)  require  amputation.4 The
ecommended  treatment  aims  to  relieve  symptoms  and  con-
ists  of  the  use  of  analgesics,  prostaglandins  and  stem  cells,
he  latter  two  remain  experimental.5,6 In  case  of  refrac-
ory  pain,  lumbar  sympathectomy  is  recommended.  The  aim
f  this  article  is  to  report  the  case  of  a  patient  with  CLI,
uccessfully  treated  with  neurolitic  block  of  the  lumbar  sym-
athetic  chain,  and  perform  a  systematic  review  of  lumbar
ympathectomy  as  CLI  treatment.
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RSB,  female  patient,  Afro-descendant,  69  years-old,  pre-
ented  with  systemic  hypertension  and  COAD;  monitorated
n  the  algology  service  due  to  difﬁcult  to  treat  lower  limb
t
v
l
ﬂain.  The  pain  was  excruciating  (numerical  verbal  scale  10),
urning  type,  more  severe  to  the  right,  which  appeared  even
t  rest  and  worsened  when  walking,  improving  when  limbs
ere  outstanding.  The  physical  examination  showed  non-
xed  cyanosis  in  right  toes  and  absence  of  popliteal,  ﬁbular
nd  tibial  pulses  in  the  ipsilateral  limb.
The  patient  had  already  undergone  various  treatments,
ncluding  multiple  surgical  interventions,  such  as  stenting
n  common  iliac  arteries  and  femoropopliteal  bypass  in
he  right  lower  limb.  However,  there  was  no  improvement
n  pain  symptoms.  He  was  taken  tramadol  (400  mg  day−1),
mitriptyline  (25  mg  day−1),  gabapentin  (300  mg  day−1),  and
ipyrone  (8  g  day−1).  Important  to  note  that  the  doses
f  amitriptyline  and  gabapentin  are  below  those  recom-
ended,  as  the  patient  had  major  side  effects  caused
y  these  two  drugs.  Arteriography  showed  right  common
emoral  artery  obstruction  and  ipsilateral  occlusion  of  the
uperﬁcial  femoral  artery.  Duplex  scanning  of  the  venous
ystem  showed  thrombus  in  left  common  and  superﬁcial
emoral  veins  and  left  popliteal  vein.  Based  on  the  clinical
icture,  the  vascular  surgery  indicated  amputation  of  the
ight  lower  limb  due  to  the  technical  difﬁculties  of  a  new
evascularization  and  the  possibility  of  worsening  symptoms
f  contralateral  limb,  also  affected  by  vascular  disease.  Due
o  intractable  pain,  the  algology  service  suggested  lumbar
ympathectomy.
After  admission  to  the  operating  room,  the  patient  was
onitored  with  cardioscopy,  pulse  oximetry,  and  noninvasive
lood  pressure;  positioned  in  the  prone  position;  sedated
ith  1  mg  of  midazolam  and  50  mcg  of  fentanyl;  and  main-et  al.  Neurolitic  block  of  the  lumbar  sympathetic
l  lower  limb  ischemia.  Rev  Bras  Anestesiol.  2016.
ained  on  spontaneous  ventilation  with  O2  supplementation
ia  nasal  catheter.  Local  anesthesia  was  performed  with
idocaine  1%.  The  blockade  was  performed  with  the  aid  of
uoroscopy,  bilaterally,  in  the  L2--L3--L4  levels  to  the  right
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and  L3  to  the  left,  both  with  a  number  22G  Quincke  needle.
Following  conﬁrmation  of  needle  positioning  and  observa-
tion  of  contrast  dispersion  in  each  level  mentioned,  3  mL  of
absolute  ethanol  with  bupivacaine  without  vasoconstrictor
(WV)  were  injected  on  the  right  side  and  20  mL  of  bupi-
vacaine  25%  WV  on  the  left  side.  The  patient,  therefore,
underwent  right  neurolitic  block  and  left  anesthetic  block,
in  order  to  achieve  vasodilation  and  central  desensitization,
with  consequent  pain  relief.  The  procedure  was  uneventful
and  after  24  hours  the  patient  was  discharged  with  complete
remission  of  the  pain.
After  over  a  year  of  the  intervention  the  patient  remains
pain  free.
Discussion
Peripheral  arterial  disease  is  quite  common.  The  estimated
worldwide  prevalence  of  COAD  is  10%.  It  is  believed,  how-
ever,  that  these  data  are  still  underestimated,  as  most
patients  remain  asymptomatic  for  a  long  time.1
COAD  has  an  insidious  course.  Patients  will  only  show
symptoms  when  more  than  50%  of  the  vessel  lumen  is
affected.  Some,  however,  remain  asymptomatic  despite  the
disease  severity  due  to  the  presence  of  a  large  network  of
collaterals  present  in  the  lower  limbs.  When  chronic  obstruc-
tion  is  not  compensated  by  the  collaterals,  critical  ischemia
occurs.  The  manifestation  of  CLI  is  severe  and  persistent
pain  at  rest  that  does  not  decrease  with  usual  analgesics,  it
worsens  when  the  limbs  are  elevated  and  decreases  when
they  are  pending,  and  may  be  associated  with  ulcers  and
gangrene.  In  more  severe  cases,  due  to  pain  severity,  the
patient  does  not  sleep  and  develop  psychiatric  disorders,
such  as  anxiety  disorder.
About  5--10%  of  patients  with  COAD  will  progress
to  critical  ischemia.1,7 The  treatment  in  these  cases  is
performed  through  revascularization  techniques,  such  as
bypass,  endarterectomy,  and  endovascular  stenting.  How-
ever,  in  some  situations  in  which  the  affected  site  cannot
be  revascularized,  the  indication  for  amputation  is  the  only
therapeutic  option,  as  other  treatments,  such  as  cell  therapy
and  the  use  of  prostaglandins,  l-arginine,  and  carnitine,  are
still  experimental  or  have  discrete  results,  respectively.8--11
Lumbar  sympathetic  blockage  arises  as  a  treatment
option  in  cases  in  which  the  pain  is  persistent,  revasculariza-
tion  is  not  feasible,  and  there  is  indication  for  amputation.
Sympathectomy  for  arterial  occlusion  treatment  is
described  since  the  beginning  of  the  twentieth  century,
when  in  1924  Jules  Diez,  used  this  technique  to  treat  a
patient  with  thromboangiitis  obliterans  in  Argentina.12 Since
then,  several  studies  have  demonstrated  the  efﬁcacy  of  this
therapy  for  patients  with  peripheral  arterial  disease.
The  pain  control  after  sympathectomy  is  primarily
related  to  the  vasodilatory  effects  that  it  has  on  the  col-
lateral  circulation.  The  increase  in  oxygenation  means  less
tissue  damage  and,  therefore,  less  pain.  Moreover,  the  inter-
ruption  of  painful  routes  maintained  by  the  sympathetic  andPlease  cite  this  article  in  press  as:  Barreto  Junior  EP,  
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the  neurolitic  direct  effect  on  nociceptive  ﬁbers  contribute
to  this  effect.  In  this  case,  absolute  ethanol  was  used,  which
causes  dehydration  of  neural  tissue,  resulting  in  sclerosis  of
nerve  ﬁbers  and  destruction  of  myelin.
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Yoshida  et  al.,13 treating  20  patients  with  peripheral  vas-
ular  disease  with  phenolic  sympathetic  blockade,  reported
hat  in  73%  of  cases  the  results  were  considered  good.  Dia-
etes  and  ankle  brachial  index  <0.3  were  associated  with
ower  success  rate.
Holliday  et  al.14 evaluated  70  patients  with  CLI  with-
ut  possibility  of  vascular  reconstruction.  The  short-term
uccess  rates  (six  weeks)  of  patients  treated  with  surgical
ympathectomy  was  44%  versus  18%  for  chemical  sympa-
hetic  blockade.  In  the  long-term  (one  year),  however,
uccess  rates  were  similar,  47%  and  45%,  respectively.  The
rocedures  were  associated  with  low  morbidity.
Sanni  et  al.15 in  a systematic  review  compiled  the  results
f  13  studies  of  the  subject  and  concluded  that  lumbar
ympathectomy  improves  on  a  sustained  basis  the  symp-
oms  of  patients  with  CLI.  They  further  state  that  it  is  a
inimally  invasive  procedure  with  few  complications  rates.
esagikar  et  al.16 by  applying  a  vascular  surgeon  question-
aire  on  indications,  outcomes,  and  complications  of  lumbar
ympathectomy,  reported  that  the  main  indication  for  lum-
ar  sympathectomy  is  pain  at  rest  in  patients  with  severe
eripheral  occlusive  disease  without  surgical  revasculariza-
ion  conditions.  Lumbar  sympathetic  blockade  was  also  used
o  treat  ulcers,  Raynaud  phenomenon,  and  as  a  ‘‘bridge’’  for
evascularization,  in  order  to  improve  the  surgical  outcome.
o  serious  complications  were  reported  by  respondents.
In  fact,  compared  to  the  surgical  blockade  the  chemi-
al  blockade  with  alcohol  or  phenol  is  safer,  less  invasive,
ith  virtually  no  morbidity  and  mortality.  Few  cases  of  uri-
ary  retention,  neuritis,  and  hematoma  were  reported  as
omplications.16
The  duration  of  analgesia  is  still  uncertain.  Some  studies
ave  shown  that,  after  a  year,  more  than  half  of  patients
emain  pain  free.  Moreover,  because  it  is  a  fairly  safe  pro-
edure,  the  chemical  blockade  could  be  performed  as  many
imes  as  necessary  to  achieve  control  of  the  painful  condi-
ion  of  the  patient.17,18
In  this  paper,  we  report  the  case  of  a  patient  with  CLI
uccessfully  treated  with  lumbar  sympathetic  block.  After
ver  a  year  of  the  intervention,  the  patient  remains  with
ontrolled  pain  symptoms  and  was  not  necessary  to  subject
im  to  amputation.
Given  the  above,  it  can  be  concluded  that  the  neurolitic
lock  of  the  lumbar  sympathetic  chain  is  an  effective  treat-
ent  option,  relatively  safe,  for  pain  control  in  patients
ith  critical  limb  ischemia,  in  which  the  only  possible  inter-
ention  would  be  amputation.  Professionals  who  work  with
hese  patients  should  remember  that  lumbar  sympathec-
omy  is  an  additional  therapeutic  strategy  that  can  be  used
n  order  to  avoid  a  surgical  traumatic  treatment,  such  as
imb  mutilating  surgeries,  which  are  associated  with  a  worse
rognosis.
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